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Abstract
Direct comparison of protein components from human and mouse excitatory synapses is important for determining the
suitability of mice as models of human brain disease and to understand the evolution of the mammalian brain. The
postsynaptic density is a highly complex set of proteins organized into molecular networks that play a central role in
behavior and disease. We report the first direct comparison of the proteome of triplicate isolates of mouse and human
cortical postsynaptic densities. The mouse postsynaptic density comprised 1556 proteins and the human one 1461. A large
compositional overlap was observed; more than 70% of human postsynaptic density proteins were also observed in the
mouse postsynaptic density. Quantitative analysis of postsynaptic density components in both species indicates a broadly
similar profile of abundance but also shows that there is higher abundance variation between species than within species.
Well known components of this synaptic structure are generally more abundant in the mouse postsynaptic density.
Significant inter-species abundance differences exist in some families of key postsynaptic density proteins including
glutamatergic neurotransmitter receptors and adaptor proteins. Furthermore, we have identified a closely interacting set of
molecules enriched in the human postsynaptic density that could be involved in dendrite and spine structural plasticity.
Understanding synapse proteome diversity within and between species will be important to further our understanding of
brain complexity and disease.
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Introduction
Over the last decade the identification of synaptic proteins using
mass spectrometry has transformed the view of the synapse as a
relatively simple structure to one with a high degree of molecular
complexity [1]. Proteomic studies from fly [2], mouse [3,4], rat
[5,6] and human [7,8] have identified many hundreds of
postsynaptic proteins that are organized through physical interac-
tions into multiprotein complexes and networks [9]. The overall
function of these structures is to mediate the contact and
communication of information between nerve cells. Furthermore,
molecular signaling within the postsynaptic terminal not only plays
key roles in rapid neuronal transmission of electrical activity, but
also in a wide range of adaptive behaviors including learning and
memory.
The first clue that the postsynaptic terminal was composed of an
unusually large, or complex set of proteins came from the intense
staining it produced when observed under the electron microscope
[10]. Beneath the postsynaptic membrane was a dense band of
material that was referred to thereafter as the postsynaptic density
(PSD). Confirmation that the PSD was composed of many
unknown proteins was obtained by gel electrophoresis of PSD
proteins isolated by fractionation of brain homogenates [11,12].
Our recent characterization of the PSD from the neocortex of
humans (hPSD) [7] revealed the role of PSD genes in known
Mendelian disorders (PSDopathies). By overlaying human genetic
data onto the PSD, we found that mutations in 207 PSD genes
(15% of PSD genes) cause diseases including 133 brain diseases.
It is important to compare mouse and human synapse
proteomes for several reasons. The extent that mouse genetic
models recapitulate features of human disease will likely be
influenced by the similarity of the protein networks in which that
gene functions. Synapse proteins control behavior and thus
differences may provide insights into changes in species behavior.
Toward validating animal models for human disease at the
molecular level and towards better understanding the evolution of
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the mammalian synapse and brain, we report what, to our
knowledge, is the first comparative proteomic study of the human
and mouse PSD. Although proteomic profiling of the mouse PSD
has been previously reported [4,13], here we compare and
contrast human and mouse PSDs isolated and analyzed in parallel
and by identical methods. Thus differences in fractionation
methods, instrument sensitivity and other parameters that differ
between laboratories and inevitably introduce significant variation
in the results are minimized. We compare the numbers, types and
abundances of PSD proteins between these two species and
present a functional classification of mammalian cortical PSD
molecules. All the data generated is freely available in the G2Cdb
database (http://www.genes2cognition.org/publications/human-
mouse-psp).
Materials and Methods
Ethics Statement
Animals were treated in accordance with UK Animal Scientific
Procedures Act (1986). All procedures were supervised by the
Wellcome Trust Ethics Committee and the UK Home Office
(Project License: 80/2337).
Human Cortex Samples
Human cortex samples and PSD proteins used in this study had
been previously described [7]. Human cortex was obtained from 9
different neurosurgical procedures. Immediately following removal
from the brain, neuropathologists assessed whether it was normal
or diseased tissue and only those samples that were designed as
normal were used in the present study.
Mouse Cortex Samples
In total 5 male and 5 female 6–8 week old mice, from the 129
Strain, were used in this study. Prior to isolation of postsynaptic
densities cortex was dissected from the rest of the brain, including
hippocampus. The 10 cortices were pooled into three groups (one
group of four and two of three) to make the three replicates used in
this study. All mouse and human sample processing steps were
performed in parallel (at the same time) and peptide fractions from
all samples analyzed back-to-back within just over a week and the
performance and sensitivity was monitored throughout.
Reagents
All chemicals were purchased from SIGMA. MOPS electro-
phoresis buffer and pre-casted 4–12% Bis-Tris SDS-PAGE gels
were obtained from Invitrogen. Antibodies were purchased from
BD bioscience (Anxa 2, 610069; Baiap2, 612674/5; Grin2B,
610416/7 and Dlg1, 610874/5), Millipore (Grin1, 05-432;
Camk2a, 05-532; Grin2a 07-632; and Rac1, 05-389), Neuro
Mab (Dlg2, 75-057 and Dlg3, 75-058), Affinity (Dlg4, MA1-045),
Sigma-Aldrich (Anxa6, HPA009650) and AbCam (Syngap1,
ab3344).
Postsynaptic Density Fractionation
Human and mouse samples were fractionated in parallel, using
the exact same methods and equipment. Postsynaptic densities
were prepared as described previously [14]. Essentially, tissue was
homogenized 9:1 (v:w) using a glass-teflon tissue grinder in a buffer
containing Tris 50 mM pH 7.4, 0.3M sucrose, 5 mM EDTA,
1 mM PMSF, 2 mM Aprotinin and 2 mM Leupeptin. A first
8006g centrifugation was used to discard nuclei and cell debris,
the supernatant was subjected to a second centrifugation at
160006g to collect a pellet containing the membrane fraction.
This was resuspended 5:1(v:w) in Tris 50 mM pH 8.1, 5 mM
EDTA, 1 mM PMSF, 2 mM Aprotinin and 2 mM Leupeptin, and
chilled in ice for 45 minutes. Solid sucrose was added to a final
34% (w/w) concentration. A sucrose gradient was prepared with
equal volumes of the following layers (bottom to top): sample, Tris
50 mM pH 7.4-0.85M sucrose and Tris 50 mM pH 7.4-0.3M
sucrose. The gradient was centrifuged for 2 hours at 600006g.
The inter-phase between 34% and 28.5% sucrose was collected,
diluted to 10% sucrose with Tris 50 mM pH 7.4 and subjected to
a 30 minutes centrifugation at 480006g. Pellet was resuspended in
3 ml of Tris 50 mM pH 7.4 to generate the synaptosomal fraction.
An equal volume of 3% Triton X-100 was added to the
synaptosomal fraction and chilled for 30 minutes in ice. Sample
was layered on top of 30 ml of Tris 50 mM pH 7.4-0.85M sucrose
and centrifuged at 1040006g for 1 hour to obtain the PSD
fractions as a pellet.
LC-MS/MS Analysis on Mouse and Human PSD Fractions
All processing of human and mouse cortical PSD fractions was
performed in parallel, using the same methods and equipment.
Our experimental analysis of the Human PSD has been described
in a previous study [7]. 25 mg of cortical PSD protein from each
purification was separated by SDS-PAGE electrophoresis using a
NuPAGE 4–12% Bis-Tris gel (1.5 mm610 well, Invitrogen) and
MOPS buffer. The gel was stained overnight with colloidal
Coomassie blue (Sigma). Each lane was excised into 32 bands that
were in-gel digested overnight using trypsin (sequencing grade;
Roche). Peptides were extracted from gel bands twice with 50%
acetonitrile/0.5% formic acid and dried in a SpeedVac (Thermo).
Peptides were resuspended using 0.5% formic acid were analyzed
online using an Ultimate 3000 Nano/Capillary LC System
(Dionex) coupled to an LTQ FT Ultra hybrid mass spectrometer
(Thermo Electron) equipped with a nanospray ion source.
Peptides were desalted on-line using a micro-Precolumn cartridge
(C18 Pepmap 100, LC Packings) and then separated using a
45 min RP gradient (4–32% acetonitrile/0.1% formic acid) on a
BEH C18 analytical column (2.1 mm6100 mm, 1.7 mm) (Waters).
The mass spectrometer was operated in standard data
dependent acquisition mode controlled by Xcalibur 2.0. The
instrument was operated with a cycle of one MS (in the FTICR
cell) acquired at a resolution of 100,000 at m/z 400, with the top
five most abundant multiply-charged ions in a given chromato-
graphic window subjected to MS/MS fragmentation in the linear
ion trap. A total of 96 LC-MS/MS analyses were performed and
108,608 MS/MS spectra were acquired. All data were processed
using BioWorks V3.3 (Thermo Electron) and searched using
Mascot server 2.2 (Matrix Science) against a Human IPI sequence
database (June, 2007) using following search parameters: trypsin
with a maximum of 2 mis-cleavages, 20 ppm for MS mass
tolerance, 0.5 Da for MS/MS mass tolerance, with 3 variable
modifications of Acetyl (Protein N-term), Carbamidomethyl (C),
and Oxidation (M). False discovery rates determined by reverse
database searches and empirical analyses of the distributions of
mass deviation and Mascot Ion Scores were used to establish score
and mass accuracy filters. Application of these filters to this dataset
resulted in a ,1% false discovery rate as assessed by reverse
database searching. Protein hits from all datasets were BLAST-
clustered using a threshold of 95% sequence identity over at least
50% of sequence length.
Our criteria for inclusion of a protein in the mouse PSD was the
same as that used for human [7]: a protein had to be identified
with at least two peptides in one of the replicates or with 1 peptide
in all of them and consensus mPSD proteins were identified with a
minimum of 2 peptides in triplicate.
Comparative Proteomics on Human and Mouse PSD
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Protein Quantification Using Intensity Based Absolute
Quantification (IBAQ)
iBAQ values were calculated using MaxQuant 1.2.0.18 [15] as
described [16].
In order to perform cross-species label-free quantification,
protein intensities and iBAQ values were calculated using only
peptides that were shared between species, that is, peptides with
100% sequence conservation. This was achieved by performing
protein identification and protein intensity calculations for human
PSD data (in MaxQuant) using a mouse protein sequence
database, and for mouse PSD data using a human protein
sequence database. Only proteins for which a quantitative value
could be measured for all replicates in both species were
considered for the analysis. Protein iBAQ values for each
individual PSD dataset were normalized and log2 transformed.
Protein expression differences between human and mouse PSD
datasets were identified using t-testing with a Permutation-based
FDR (0.01) to correct for multiple hypothesis testing (Perseus
v1.2.0.17). Hierarchal clustering analysis was performed using
Perseus v1.2.0.17 using Euclidean distance.
Proteomic Data Integration
In order to compare the sets of PSD proteins identified from
mouse and human cortical samples, we mapped the IPI protein
identifiers back to their respective genomes via UniProt, or
sequence search, using the Ensembl gene annotation database
[17]. In the cases where a clear 1:1 orthologue was not predicted
by Ensembl, we manually searched by gene symbol on the Mouse
Genome Informatics (MGI [18]) and HUGO Gene Nomenclature
Committee (HGNC [19]) database websites in an attempt to find
the orthologous pair.
Analysis of Sequence Conservation in Coding Sequences
of PSD Genes
dN and dS values were obtained from Ensembl version 62 [20]
and dN/dS ratios computed (Table S10). Differences between
dN/dS distributions between dataset were computed using the
Mann-Whitney U test.
Bioinformatic Functional Analysis of PSD Proteins
All functional analyses were done using the Panther 7.0
Classification System [21] and its expression analysis tool [22].
Biological Process terms were used as defined by the Gene
Ontology Consortium [23]. The Panther terms ‘Protein Class’ and
‘Pathway’ were also used. In all cases binomial statistics were used
to find enriched terms only amongst consensus PSD proteins. To
correct for multiple testing the Benjamini-Hochberg false discov-
ery rate procedure was applied. All enrichment analysis were done
using the human genome as a background set.
Interaction Network
Protein interactions were obtained from the database of protein
associations STRING [24]. Interactions with a confidence score
below 0.4 were not considered for the final map and proteins
without interactions were excluded. The interaction map was built
with BioLayout Express [25]. Edge color reflects confidence score;
red being maximum confidence (1) and blue minimum (0.4). Node
clustering was done with BioLayout using the Markov Clustering
Algorithm.
Results
Overall Similarity of the Mouse and Human Postsynaptic
Proteomes
Triplicate postsynaptic density (PSD) fractions were isolated
from whole mouse cortex (mPSD) and human cortex (hPSD;
reported earlier, pooled from 9 different regions from the
temporal, frontal and parietal lobes [7]). Here we report the data
from the mPSD and its comparison with the human. In all
triplicate mPSD samples immunoblotting of synaptosomal and
PSD fractions for well-known PSD components (Figure 1a)
revealed clear enrichment for all tested PSD proteins; conversely,
the pre-synaptic marker synaptophysin was depleted from PSD
fractions.
Subsequent proteomic profiling of the three mPSD samples by
high resolution tandem mass spectrometry (MS) identified a total
of 1556 proteins of which 984 were found in triplicate and
constitute the consensus mPSD (Table S1). These numbers are
similar to what was found in the hPSD, which showed 1461 total
and 748 consensus proteins. Using orthologous relationships
between human and mouse proteins, we found ,70% overlap
between human and mouse PSD lists, leading to a combined count
of 1998 cortical PSD proteins identified in humans and mouse.
To quantify intra- and interspecies PSD protein abundance
differences we performed ‘intensity-based absolute quantification’
(iBAQ) using raw MS data to measure protein abundance [16].
Briefly, it allows the relative abundance of proteins to be calculated
by summing all peptide 3D peak intensities detected for a given
protein in a set of LC-MS/MS experiments and normalizing it by
the number of theoretically observable peptides under the
experimental conditions used. Only proteins for which a
quantitative value could be measured for all replicates in both
species were considered for the analysis (see methods, Table S2)
and iBAQ values for each replicate were normalized to account for
any discrepancies in total protein amounts loaded on gels.
High correlations were observed between intra-species protein
abundances (human, r = 0.8960.006 and mouse r = 0.9560.01;
Figure 1b,c), clearly indicating the reproducibility and validity of
the protein quantification approach used. This is important for the
human set as it was derived from nine samples from different
cortical locations, and confirms that the mixing of these samples
resulted in three equivalent/averaged cortical PSD samples.
Between species, the correlation of overall abundance was also
significant (r = 0.74, p,0.0001 Fig. 1d) although substantially
lower: in other words, inter-species differences in abundance are
much larger than intra-species differences.
Glutamate receptors and scaffold proteins are constituents of
well-known protein complexes embedded in the PSD. It is of
interest to ask if the proteins that form these complexes show a
different degree of variation between humans and mice than the
rest of the PSD. To address this question, we computed the
correlation coefficients between human and mouse for subsets of
PSD proteins belonging to the NMDA receptor [3], PSD-95 [26]
and mGluR5 [27] complexes (Fig.1e–g and Table S2). This
analysis showed that the abundance of components of these
complexes were not significantly different (unpaired t-test with
Welch’s correction, p.0.05) from the whole PSD datasets.
Hierarchical clustering analysis of all replicates also indicates that
mouse and human samples group together (Fig. 1h), bolstering the
observation of higher similarity of intra-specific protein abun-
dance.
Based on hPSD data we had previously shown that PSD protein
coding sequence has been under very strong evolutionary
(purifying) constraint since mouse and human diverged 90 million
Comparative Proteomics on Human and Mouse PSD
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years ago [7]. To re-evaluate this observation with the mouse
proteomic data, which has over 500 proteins not detected in
humans (Figure 2a), we again used the dN/dS ratio to measure
protein conservation. While dN measures the rate of mutations
causing amino acid substitutions, dS accounts for synonymous
changes and represents the background rate of DNA change. Low
dN/dS values indicate evolutionary conservation while high values
imply the opposite [28]. The mPSD dN/dS ratio was significantly
lower than that of the whole genome while equivalent to the hPSD
(Figure 2a). Furthermore, the consensus set of mouse postsynaptic
molecules was more conserved than the whole set, as we previously
found in humans [7]. These data confirms that natural selection
exerts strong protein sequence constraint in both mouse and
human PSD proteins. We also found that proteins exclusive to
each species have a significantly higher dN/dS than the rest of
PSD genes (human p,0.0001; mouse p= 0.0002) or genes
differentially expressed between species (human p,0.0001; mouse
p= 0.004; Figure 2b).
Species Expression Differences in Key PSD Proteins
It is important to ask if differences in the composition of the
hPSD and mPSD arise as a result of differences in expression of
particular proteins. Addressing this issue is challenging given that
the human cortex is a thousand-fold larger than the mouse cortex
and our limited sampling of 9 human regions is not expected to
capture the full range of diversity within the cortex. Nevertheless,
consistent with the observed similarity of the triplicate hPSD
samples, a recent systematic study of transcriptome expression in
human brain regions (including many areas of the cortex) show
that different cortical regions have generally very similar overall
gene expression patterns [29]. For the purposes of the next
analyses we will make the assumption that our 9 human samples
are representative of all human cortical regions and examine the
null hypothesis that the hPSD and mPSD are the same.
As referred to above, comparison of the human and mouse PSD
lists revealed that ,70% of the total and 73% of the consensus
hPSD proteins were present in the mouse PSD (Figure 3a,b and
Table S1). We selected two of the proteins that were only
identified in the hPSD (Annexin 2 and 6) by MS and validated that
they were in fact specific to the human PSD by western blot
(Figure 3c) thereby reinforcing observations based on MS data
alone. We next asked if the ,30% of PSD proteins found in the
postsynaptic density of only one of the two species (Table S3)
might confer some functional difference. To address this question,
we compared their functional properties using the Panther
Classification System [21]. Most protein classes showed no
significant difference between species (Table S4), suggesting that
the functional similarity between human and mouse PSD extends
beyond the 70% of identical proteins. However, some functional
groups were differentially enriched in one of the species (Table 1):
for example a larger number of ion channels, particularly calcium
channels, as well as molecules related to protein translation were
found in the mPSD. Conversely, the hPSD showed enrichment in
cytoskeletal components and some enzyme types (i. e. reductases,
transferases, dehydrogenases; Table 1). Although protein kinases
(PK) were enriched amongst all human PSD proteins, this was not
observed if only consensus hPSD molecules were considered
(Table 1).
To further pursue the possibility that protein expression levels
could confer functional difference between human and mouse, we
Figure 1. Validation of fractionation method and quantitative comparison of mouse and human cortical PSDs. a. Immunoblots of
known postsynaptic density components. Mouse synaptosomes (S) and PSD (P) fractions are analyzed for each of the three replicates. All proteins
show enrichment in the PSD compared to synaptosomes. The presynaptic marker synaptophysin (Syn) is only detected in the synaptosomal fraction.
Only genes identified in triplicate in both species were considered for the quantitative analysis. Correlations are calculated based on linear models.
Coefficients of correlations are represented by r. Examples of intra-species protein abundance correlation: b. human PSD first replica against second;
c. mouse PSD first replica against second. d. Plot of average values of PSD proteins abundance from human and mouse cortex. e. Protein abundance
correlation of PSD components found in the NMDA receptor complex [3]; the PSD-95 complex [26] (f), and the mGluR5 complex [27] (g). h. Clustering
of PSD protein abundance values for human and mouse replicates.
doi:10.1371/journal.pone.0046683.g001
Figure 2. Analysis of evolutionary conservation of PSD proteins in mouse and humans. a. Median dN/dS of proteins identified in the
human PSD, mouse PSD and mouse consensus set (cPSD) compared with the median genomic value. b. Comparison of dN/dS values in proteins
exclusive or enriched in one species with all PSD proteins.
doi:10.1371/journal.pone.0046683.g002
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examined the abundance of proteins found in both species using
iBAQ values. Of all proteins found in both species ,8% were
differentially expressed (p,0.05) in the human set and ,10% in
the mouse set (Table S2). Surprisingly, many important compo-
nents of the PSD identified by previous rodent studies were
amongst the proteins with greatest inter-species abundance
differences, being almost in all cases more abundant in mouse
(Table 2). Many proteins overrepresented or exclusive to the
mouse PSD are relevant to synaptic transmission as shown by an
analysis of gene ontology (Table S5). Interestingly, the abundance
fold difference (AFD) between mouse and human showed
considerable variation between canonical PSD molecules. For
example, CAMK2A and CAMK2D have similar expression level
in both species while PSD95 (DLG4) is almost 5-fold more
abundant in the mouse PSD (Table 2). Moreover, the 4 members
of the PSD95 family (DLG1-4) are on average 6-fold more
abundant in the mouse PSD (average AFD: 5.9661.2; Figure 3d)
while another class of PSD scaffold proteins, the DLGAPs, showed
more individual variability (i.e. DLGAP1 AFD=3.4 while
DLGAP4 AFD=16.6, Figure 3d). This was also the case for
subunits of the AMPA and NMDA type glutamate receptors
(AMPAR and NMDAR respectively). AMPAR subunit’s AFD was
very variable; (average AFD: 9.969.3) while NMDAR subunit’s
abundance difference was less (average AFD: 6.761.5). Within the
PSD are MAGUK Associated Signaling Complexes (MASC) that
contains PSD-95 family, DLGAPs, NMDAR and over 100 other
proteins [26] and the individual components show wide variability
(average AFD: 5.8621.5). Altogether our data suggests that there
are important abundance difference in the cortex of human and
mouse for some proteins key to synaptic biology.
Species Differences in Morphogenesis and Semaphorin
Signaling
To gain further insight into functions that might distinguish
human and mouse synapses, we performed gene ontology (GO)
analysis. Enrichment in GO categories revealed the Biological
Process category ‘cellular component morphogenesis’ amongst the
most enriched categories by genes exclusive or enriched in the
Figure 3. Inter-species differences on postsynaptic density proteins. a. Venn diagrams showing the total amount of proteins in mPSD and
hPSD as well as the overlap between them relative to the hPSD. b. Venn diagrams showing the proteins identified in triplicate for the mPSD and
hPSD, the overlap relative to hPSD between the two sets is also shown. c. Immunoblot validation of proteins identified only in the hPSD by mass
spectrometry. The following samples were analyzed: H-M, mouse brain homogenate; H-H, human brain homogenate; and SX, each of the three
synaptosomal fractions, PX, each of the three postsynaptic density fractions for both species. d. The abundance fold difference (AFD) between mouse
and human is shown for members of adaptors, channels and neurotransmitter receptors protein families. AFD is calculated as the mouse to human
ratio of normalized and log2 transformed average abundance values. For each protein family the number of proteins displayed is given in brackets.
doi:10.1371/journal.pone.0046683.g003
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hPSD (p= 0.0004); other terms hierarchically related to it also
appeared enriched in this analysis (Figure 4a and Table S6). Genes
enriched or exclusive to the human PSD also showed enrichment
in the pathway ‘axon guidance mediated by semaphorins’
(p = 0.01; Table S5).
To further explore the enrichment of semaphorin function in
humans we examined the A Plexins, which bind Semaphorins 3A
and 3F [30]. All four A Plexins showed greater abundance in
hPSD compared to mPSD: PLXNA2 and PLXNA3 were
exclusive to hPSD and PLXNA1 and PLXNA4 were over two-
fold more abundant in hPSD (Table S7). Plexins interact with the
family of collapsin response mediator proteins (CRMPs, currently
named DPYSLs) [31]: four of the five members of this family are
in the PSD, all being much more abundant in human (Table S7).
We then asked if the molecules enriched in the human PSD
related to semaphorin signaling or to cellular component
morphogenesis, could form a functional complex within the
PSD. To address this question, we searched for protein
interactions between these molecules (Table S7) and plotted them
into an interaction network (Figure 4b). Most of the molecules (28/
34) interact with other members of this group and overall the
interaction map is highly interconnected, suggesting that this is a
set of closely interacting molecules that might constitute a PSD
sub-structure that is more abundant in the human cortical PSD.
Further studies will be required to determine if there are
biologically relevant differences in semphorin signaling in mouse
and human tissue.
Bioinformatic Functional Analysis of the Mammalian
Cortical PSD
Considering together the two PSD structures derived from
human and mouse cortex the total number of proteins identified is
1998 (Table S1). This is an unusually large number for a biological
supramolecular protein complex, around 10% of the human or
mouse genomes, and therefore it is interesting to study its main
functional properties as a way to understand its overall organiza-
tion. The functional analysis was performed with the Panther
Classification System, which classifies proteins according to
predicted function (see methods). Although most Panther Protein
Classes were represented by some of the 1998 PSD proteins only
,30% of them were significantly over or underrepresented with
PSD proteins when compared with the human genome (Figure 5
and Table S8). These enrichments suggest that the mammalian
PSD is a specialized molecular machine.
Signaling pathways related to the metabotropic and ionotropic
glutamate receptors were amongst the most enriched, proving the
validity of the methodology used. Amongst signaling molecules
protein kinases, small GTPases and G-proteins are all enriched in
the PSD compared to the genome; while others, such as cyclases
and protein phosphatases were not (Table S8). Interestingly,
although the PSD has signaling components from many different
pathways, not all these pathways are equally represented in the
PSD as reflected by the enrichment p-values (see methods, Table
S9). Molecules involved in translation (i.e., RNA binding protein,
Table 1. Significantly enriched protein classes of species-specific PSD proteins.
PSD proteins Consensus PSD proteins Enriched in
PANTHER Protein Class Proteins Identified p-value Proteins Identified p-value
cytoskeletal protein 36 1.3E209 16 3.6E207 Human
actin family cytoskeletal protein 22 7.6E208 10 3.4E205 Human
oxidoreductase 39 5.2E209 13 5.1E204 Human
Dehydrogenase 22 4.5E208 8 8.9E204 Human
non-motor actin binding protein 14 3.4E206 6 1.4E203 Human
Reductase 8 1.1E203 4 1.4E202 Human
Transferase 70 1.4E208 18 2.5E202 Human
microtubule family cytoskeletal protein 11 5.9E203 5 3.3E202 Human
transfer/carrier protein 14 8.5E203 6 4.3E202 Human
membrane trafficking regulatory protein 16 4.7E208 4 4.3E202 Human
nucleotide kinase 10 3.4E206 3 4.3E202 Human
membrane traffic protein 27 4.7E208 5 3.0E201 Human
Kinase 40 1.2E207 8 3.0E201 Human
protein kinase 25 1.2E203 5 7.6E201 Human
enzyme modulator 33 6.5E203 7 7.9E201 Human
G-protein modulator 15 8.5E203 1 1.0E+00 Human
ribosomal protein 29 8.0E213 16 2.3E209 Mouse
calcium channel 7 2.9E204 6 3.9E205 Mouse
RNA binding protein 60 1.2E213 20 3.9E204 Mouse
ion channel 31 3.7E208 12 2.1E203 Mouse
nucleic acid binding 78 6.7E209 28 2.5E203 Mouse
SNARE protein 8 1.1E204 4 9.4E203 Mouse
Transporter 57 4.1E206 19 8.8E202 Mouse
ligand-gated ion channel 11 9.6E204 4 2.2E201 Mouse
doi:10.1371/journal.pone.0046683.t001
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Table 2. Abundance of canonical PSD components as defined by studies with rodent brains.
Appr
Gene (m)
Appr
Gene (h)
Abundance Fold
Difference (Mouse/Human)
Significant
Enrichment (p,0.05)
Appr
Gene (m)
Appr
Gene (h)
Abundance Fold
Difference (Mouse/Human)
Significant
Enrichment (p,0.05)
Ablim1 ABLIM1 1.3 Gria3 GRIA3 4.3 Mouse
Baiap2 BAIAP2 3.1 Gria4 GRIA4 23.8 Mouse
Begain BEGAIN 10.4 Mouse Grin1 GRIN1 7.7 Mouse
Cacng2 CACNG2 2.6 Grin2a GRIN2A 5 Mouse
Camk2a CAMK2A 1 Grin2b GRIN2B 7.5
Camk2b CAMK2B 3.4 Homer1 HOMER1 3.7 Mouse
Camk2d CAMK2D 0.9 Homer2 HOMER2 1.7
Capza2 CAPZA2 1.6 Iqsec1 IQSEC1 2.4
Cntnap1 CNTNAP1 0.5 Iqsec2 IQSEC2 2.7 Mouse
Cntnap2 CNTNAP2 2.1 Kalrn KALRN 8.3 Mouse
Dlg1 DLG1 5.3 Mouse Kcnab2 KCNAB2 4.4
Dlg2 DLG2 6.3 Mouse Kcnq2 KCNQ2 0.9
Dlg3 DLG3 7.5 Mouse Lgi1 LGI1 11 Mouse
Dlg4 DLG4 4.9 Magi2 MAGI2 0.5
Dlgap1 DLGAP1 3.5 Mouse Nlgn2 NLGN2 4.4
Dlgap2 DLGAP2 8.3 Mouse Nrxn1 NRXN1 1.5
Dlgap3 DLGAP3 8.3 Mouse Nrxn3 NRXN3 3.8 Mouse
Dlgap4 DLGAP4 16.6 Mouse Rac1 RAC1 1.7
Gabbr1 GABBR1 5.8 Shank2 SHANK2 8.4 Mouse
Gabbr2 GABBR2 3.8 Mouse Shank3 SHANK3 6.5 Mouse
Gabra1 GABRA1 2.6 Syngap1 SYNGAP1 5.9 Mouse
Gnas GNAS 1.1 Ywhae YWHAE 1
Gria1 GRIA1 6.7 Ywhah YWHAH 0.5 Human
Gria2 GRIA2 4.8 Mouse Ywhaq YWHAQ 0.6
Mouse to human abundance difference of proteins known to be key components of the postsynaptic density, as derived from studies on mouse and rat brains. Abundance is expressed as the fold of mouse to human average
abundance values.
doi:10.1371/journal.pone.0046683.t002
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p= 2.48610210; ribosomal protein, p= 2.8610220), amino acid
transport, exocytosis and calcium channels (p = 2.861024) are also
found to be significantly enriched in the postsynaptic machinery
(Figure 5). Interestingly, other cation channels, such as sodium or
potassium are not enriched in the PSD; likely reflecting the more
central role of calcium in the biology of the spine. Some protein
classes were also underrepresented in the PSD when compared
with the genome (Figure 5 and Table S8). Particularly significant is
the depletion of transcription factors (p = 1.9610242); molecules
related to the immune system (i.e. cytokines p = 9.261023);
extracellular signaling molecules such as peptide hormones
(p = 0.018), and proteases (p = 0.025) and their inhibitors
(p = 0.024).
Signaling pathway enrichment analysis (Table S9) revealed
overrepresentation in the PSD. For instance, the WNT and PI3K
signaling pathways, which have been proposed to be involved in
the pathophysiology of schizophrenia [32,33,34], are enriched in
the PSD, as are the cadherin, EGF and Hedgehog signaling
pathways. In contrast FGF, TGFb, p53, IGF, VEGF, PDGF or
Toll-Receptor signaling pathways, amongst others, are not
overrepresented in the PSD proteins, suggesting that they might
have a lesser role in postsynaptic biology.
Finally we also analyzed whether molecules related to the main
neurodegenerative diseases were present in the PSD. Interestingly,
only some of these diseases show and overrepresentation of their
related proteins in the PSD. Molecules involved in Huntington’s
(p = 7.3610215) and Parkinson’s (p = 1.1610213) diseases are very
much enriched in the PSD, while those related to Alzheimer’s
(‘Alzheimer disease-presenilin pathway’, p = 0.4 and ‘Alzheimer
disease-amyloid secretase pathway’, p = 0.05; Table S9) were not
significantly enriched within PSD genes. These results suggest that
dysfunction of the PSD could be more closely linked to the
pathology of Huntington’s, which has already been proposed as a
synaptopathy [35], or Parkinson’s.
Figure 4. Functional analysis of proteins enriched in the human PSD. a. Ontology hierarchical tree leading to the Biological Process ‘Cellular
Component Morphogenesis’. In red are the terms significantly enriched in proteins abundant in the human PSD. b. Molecular interaction map of
proteins from the human PSD that belong to the Biological Process ‘Cellular Component Morphogenesis’ (CCM) or are known to be involved in
semaphorin signaling. Only CCM proteins enriched in the human PSD are considered. Some proteins related to semaphorin signaling are not
enriched in either species, these are identified with a white name. Proteins highly interconnected are represented in clusters of different colors.
Clustering was done using the Markov Clustering Algorithm (MCL) in BioLayout Express 3D [24]. Node edges are coloured according to a confidence
score, from red (100% confidence) to blue (40% confidence).
doi:10.1371/journal.pone.0046683.g004
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Discussion
This study reports the first parallel comparative proteomic
analysis of the human and mouse postsynaptic density, a key
structure underlying brain function and animal behavior. Using
samples of cortex obtained from mice and humans, the PSD was
isolated and its protein composition interrogated by MS. A similar
proteome complexity was observed in mouse (1556 proteins in
total PSD, 984 in consensus) and human (1461 total, 748
consensus). The finding that PSD molecules have been under a
very strong evolutionary purifying constraint since the divergence
of primate and rodent lineages [7] is further confirmed when
analyzing the molecules from mouse.
The molecular composition of the PSD in human and mouse
cortex is very similar, with more than 70% of hPSD proteins in the
mPSD. Computational functional analysis indicates that genes
specific to each species (in the remaining 30%) do not introduce
overall differential functional properties between species, suggest-
ing that the PSD is even more similar at the functional level than
at the composition level.
We have measured the protein abundance of PSD proteins
identified in mouse and human cortex and its comparison
indicates that they are broadly correlated, which supports the
findings obtained from transcriptomic data [29,36,37]. Neverthe-
less, we have shown that protein abundance is much more variable
between species than within species, suggesting that some of the
mechanisms that control protein expression and turnover in
cortical synapses vary between species. Since we have shown that a
very similar set of proteins are present in the human and mouse
PSD and that these have been under strong evolutionary
constraint, the differences between species are more likely to be
consequence of gene regulatory differences that influence expres-
sion and abundance.
Most well-known PSD components defined in rodent studies are
more abundant in the mouse PSD. For instance, the molecules
associated with PSD95 forming signaling complexes [26] have, on
average, an abundance fold difference between mouse and human
(AFD) of 5.8621.5. This enrichment of canonical postsynaptic
molecules in the mouse PSD could be a consequence of the mouse
cortical anatomy; as mouse cortex has been reported to have a
spine density up to three times higher than that of human cortex
[38]. This could affect the fractionation efficiency, yielding a more
enriched PSD preparation from mouse tissue. Nevertheless, if this
was the sole reason behind abundance differences between species
we should observe a more or less constant AFD between species,
and this is not the case. The AFD between mouse and human
varies considerably, even for key postsynaptic molecules, as
indicated by the high standard deviation of the average AFD of
PSD95 complex components. Interestingly, we have seen that
components of some families of postsynaptic proteins show little
AFD variation while the components of other families vary much
Figure 5. Functional protein groups with the mammalian cortical PSD. The mammalian cortical PSD was defined by combining all proteins
identified in mouse and human. This set of PSD proteins were then functionally classified using the Panther Classification descriptor ‘Protein Class’.
Enrichment analysis was done comparing the number of PSD proteins per class with the genome. The Panther Protein Class ontology is hierarchically
organized, only end-branch classes are displayed to remove redundancy from the graph (all data in Table S8). Protein classes that did not show
difference with the genome after correction for multiple testing are shown in blue. Classes overrepresented are shown in red and classes
underrepresented are shown in green.
doi:10.1371/journal.pone.0046683.g005
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more. These large inter-species abundance differences in individ-
ual proteins could translate into important functional differences
and are the most important source of disparity we have observed
between the mouse and human PSD proteomes.
Amongst proteins exclusive or enriched in the human PSD we
have identified a set of molecules that are highly interconnected
and are involved in cellular morphogenesis and semaphorin
signaling. Semaphorins are better known for their role in axon
guidance but several recent studies have elucidated their function
in dendrite and spine morphology [30,39,40,41,42]. The fact that
some of these molecules (DPYSL2 or PLXNA4) have also been
identified in human postsynaptic complexes isolated by affinity
purification (data not shown) strengthens their likelihood of being
true PSD components. We propose that these molecules interact
together as a protein complex within the PSD and are involved in
processing semaphorin signaling at spines. Their higher abun-
dance suggests that they might have a different or more relevant
role in humans. It has been shown that the expression of
semaphorin receptors in mouse cortex is very much reduced in
adulthood [39,40] while in human adult cortex expression remains
high (Allen Brain Atlas). To what extent this differentially
expressed set of molecules had any role in development of higher
cognitive abilities in humans will certainly need further investiga-
tion.
Synapse proteome differences at the level of single synapses is
also a potential explanation for the observed species differences.
The proteomic methods here define composition from large
populations of synapses and these populations are known to be
made of different types. For example, expression of neurotrans-
mitter receptors (such as NMDA receptor subunits) is distinct on
different excitatory synapses. Until synapse proteomic methods
can resolve quantitative differences in individual synapses it is
unclear if the populations of synapse types in human and mouse
neocortex are the same.
The data gathered on the mammalian PSD has prompted us to
update and extend our knowledge of the main protein families and
signaling pathways likely to be important to PSD function. We
have shown that although many protein functions are represented
amongst PSD proteins only some are enriched within the PSD
suggesting a prominent role for them. These include neurotrans-
mitter receptors, calcium channels, kinases, adaptors, amino acid
transporters or small GTPases amongst others. Similarly, we have
seen that amongst the many signaling pathways found in the PSD,
some are better represented suggesting that they might have a
particularly important role. These include the WNT and PI3K
pathways, which have been associated with schizophrenia
[32,33,34]. Finally, PSD molecules show a surprisingly high
enrichment in genes involved with Huntington’s and Parkinson’s
disease, although this is not the case for Alzheimer’s disease, which
in our study seems poorly enriched in PSD proteins although
synaptic dysfunction is well characterized as a major symptom of
Alzheimer’s [43]. In conclusion, these comparative data provide a
robust foundation for future comparative studies of mouse and
human in the context of evolution and disease.
Supporting Information
Table S1 Protein Identifications and Proteomic Data. For each
identified protein several identification (ID) numbers from
biological databases are given. The number of total and uniquely
identified peptides for each replicate is also provided. Proteins
found with two or more peptides in all replicates are classified as
members of the consensus mouse PSD. Human orthologues to
mouse proteins are provided. Data regarding human PSD proteins
is from: Bayes A et al. Nat Neurosci. 2011 Jan;14(1):19–21.
(XLSX)
Table S2 Human and Mouse PSD Proteins Abundance.
Individual and average abundance values (iBAQ) for mouse and
human PSD proteins are given. Data was normalized and log2
transformed. Normalization was achieved by dividing abundance
data points by its species abundance average. Abundance fold
difference was defined as the ratio of mouse to human average
abundance values. To measure significant abundance differences
between species a Student’s t-test was used. Proteins significantly
enriched in one species are shown in separate sheets. The
abundance of proteins from the postsynaptic protein complexes
shown in figure 1 are also shown in a separate sheet.
(XLSX)
Table S3 PSD Proteins Identified Only in One Species. Proteins
only found in human or mouse are shown in separate sheets. For
each protein several identification (ID) numbers from biological
databases are given.
(XLSX)
Table S4 Protein Classes Overrepresented in Proteins Unique to
Each Species. Proteins from the total PSD exclusive to human or
mouse were classified independently using the Panther ‘Protein
Class’ descriptor. Enrichment analysis was done to determine
Protein Classes overrepresented in each species set of exclusive
molecules. The Benjamini-Hochberg procedure was used to
correct for multiple testing. The column ‘observed’ retrieves the
number of proteins identified in each ‘Protein Class’ while the
column ‘expected’, the number that would have been identified by
chance. Over or under-representations are shown by a (+) or (2)
symbol respectively. A second sheet contains the same analysis but
done only for the molecules from the consensus PSD.
(XLSX)
Table S5 Pathways Overrepresented in Proteins Unique or
Enriched to Each Species. Proteins from the consensus PSD
exclusive or significantly enriched in human or mouse were
classified independently using the Panther ‘Pathway’ descriptor.
Enrichment analysis was done to determine Pathways overrepre-
sented in each species set of specific proteins. The Benjamini-
Hochberg procedure was used to correct for multiple testing. The
column ‘observed’ retrieves the number of proteins identified in
each ‘Pathway’ while the column ‘expected’, the number that
would have been identified by chance. Over or under-represen-
tations are shown by a (+) or (2) symbol respectively.
(XLSX)
Table S6 Biological Processes Overrepresented in Proteins
Unique or Enriched to Each Species. Proteins from the consensus
PSD exclusive or significantly enriched in human or mouse were
classified independently using the Gene Ontology (GO) term
‘Biological Process’. Enrichment analysis was done to determine
Biological Processes overrepresented in each species set of specific
proteins. The Benjamini-Hochberg procedure was used to correct
for multiple testing. The column ‘observed’ retrieves the number
of proteins identified in each ‘Biological Process’ while the column
‘expected’, the number that would have been identified by chance.
Over or under-representations are shown by a (+) or (2) symbol
respectively.
(XLSX)
Table S7 Proteins Related to Axon Guidance or Cell Morphol-
ogy. Proteins shown are either members of the group of molecules
involved in ‘axon guidance mediated by semaphorins’, as defined
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by Panther, or are known to be involved in this process (literature),
or belong to the Biological Process: ‘‘cellular component
morphogenesis’. Of all molecules belonging to the later group
only those that are unique or significantly enriched in human PSD
were considered.
(XLSX)
Table S8 Functional Comparison of all PSD Proteins Identified
in Human and Mouse. All human and mouse PSD proteins were
classified together using the Panther ‘Protein Class’ descriptor. An
enrichment analysis was done to determine Protein Classes
overrepresented compared with the human genome. The
Benjamini-Hochberg procedure was used to correct for multiple
testing. The column ‘observed’ retrieves the number of proteins
identified in each ‘Protein Class’ while the column ‘expected’, the
number that would have been identified by chance. Over or
under-representations are shown by a (+) or (2) symbol
respectively.
(XLSX)
Table S9 Pathway analysis of all PSD Proteins Identified in
Human and Mouse. All human and mouse PSD proteins were
classified together using the Panther ‘Pathway’ descriptor. An
enrichment analysis was done to determine Pathways overrepre-
sented compared with the human genome. The Benjamini-
Hochberg procedure was used to correct for multiple testing.
The column ‘observed’ retrieves the number of proteins identified
in each ‘Pathway’ while the column ‘expected’, the number that
would have been identified by chance. Over or under-represen-
tations are shown by a (+) or (2) symbol respectively.
(XLSX)
Table S10 Analysis of dN/dS values from mouse and human
PSD proteins. dN, dS, dN/dS and median dN/dS values are given
for proteins found in human and mouse cortical PSD, and proteins
exclusive or significantly enriched to each species’ PSD. All values
were obtained from Ensembl 62.
(XLS)
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